You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Research and development (R&D) as well as innovation are the drivers of change and the key determinants of growth in many industry and service sectors. In spite of the financial turmoil and restructuring of the world economy after 2008, investment in R&D is expected to grow further. Innovation competence will continue to be a major success factor for internationally operating companies. The book presents a state-of-the-art account of innovation management and the role of R&D and innovation strategy for corporate growth and renewal. It follows a top-down approach starting from corporate strategy, and describes the effective integration of corporate R&D, business unit projects and operational performance improvements. The book offers portraits of leading innovators and high-performing corporations and provides a rich collection of best-practice examples.
Proceedings of the 11th European Society for Neurochemistry Meeting held in Groningen, The Netherlandes, June 15-20, 1996
Timo B. Poser shows that Corporate Venture Capital offers a broad set of advantages, but has a limited impact on sustainable competitive advantage of the investing firm.
The rapid growth of interest and research activity in ion channels is indicative of their fundamental importance in the maintenance of the living state. This volume was prepared with a view toward providing a sampling of the range of molecular and physical methods that are significant for the study of ion channels. As part of the Reliable Lab Solutions series, Essential Ion Channel Methods brings together chapters from volumes 293 and 294 of Methods in Enzymology. The chapters have been selected by the editor and updated, when possible, by their original authors to include new research and references. The result is a set of chapters which make use of graphics, comparisons to other methods, a...
The biopharmaceutical market has come along way since 1982 when the first biopharmaceutical product, recombinant human insulin, was launched. Over 120 such products are currently being marketed around the world including nine blockbuster drugs. The global market for biopharmaceuticals, which is currently valued at US$41 billion, has been growing at an impressive compound annual growth rate of 21% over the previous five years. With over one third of all pipe-line products in active development are biopharmaceuticals, this segment is set to continue outperforming the total pharmaceutical market and could easily reach US$100 billion by the end of this decade.
Volatile organic compounds (VOCs) have been intensively investigated in the last few decades. Their origins differ: plant secondary metabolites, food/beverages aromas, fungal/bacterial volatiles, and others. VOCs typically occur as complex mixtures of compounds (e.g., monoterpenes, sesquiterpenes, norisoprenoids, aliphatic/aromatic compounds, sulfur containing compounds, and others). They form through different biochemical pathways and can be modified or created during drying or maturation, thermal treatment, and others. Different conventional or modern methods of VOCs isolation, followed by the analysis with chromatographic and spectroscopic techniques, usually provide different chemical pr...
Contains reprints of articles published by members of the department.
Betriebswirtschaftliche Kalküle bestimmen zunehmend den Arbeitsalltag von Ärztinnen, Ärzten, Krankenschwestern und Pflegern in deutschen Krankenhäusern. Die Vorgaben resultieren dabei wesentlich aus politisch festgesetzten Sparzwängen und dem Bemühen, das Überleben der jeweiligen Häuser unter Wettbewerbsdruck sicherzustellen. Inwieweit gerät diese Ökonomisierung mit dem traditionell am Patientenwohl ausgerichteten Ethos des medizinischen und pflegerischen Personals in Konflikt? Wie wirkt sich ein solcher Konflikt auf das Vertrauen der Patienten in die Angehörigen von Pflege und Ärzteschaft aus? Und schließlich: Kann das medizinische Personal seinem Berufsethos noch folgen, wenn ...